Abstract: Leukemia, a cancer characterized by the rapid overproduction of abnormal blood cells, presents notable diagnostic and treatment challenges. Identifying leukemia subtypes promptly and ...
PALO ALTO, Calif., Sept. 06, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback